The Global Viral Hepatitis Summit – 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)
Estrel Hotel & Convention Center Berlin Germany *Berlin, GERMANY Visit the Venue to read more
I have the great pleasure in inviting you to the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) to be held from June 26th to 28th, 2015, in Berlin, Germany.
ISVHLD has a long tradition of 43 years. Initially, it focused on the discovery of the hepatitis viruses, then on the development of diagnostic procedures and vaccines as well as on understanding the pathophysiology. Today, therapies have become the focus of research and in 2015 many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. Public Health becomes increasingly important. Identification of patients in need of therapy is a major challenge to make these new therapies accessible to all parts of the world. Furthermore, we still need to develop better and finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.
This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances to combat this very important global health burden caused by all hepatitis viruses. For the first time, this symposium takes place in Germany’s capital Berlin.
The 15th ISVHLD will be held together with the 12th Annual Meeting of the German national network of competence on viral hepatitis (Hep-Net) and the 1st International Symposium of the Hepatitis Section of the German Center for Infection Research (DZIF).
It is our vision and ambition to make it a true Global Viral Hepatitis Summit.
We look forward to welcoming you in Berlin in June 2015.
Professor Michael P. Manns, M. D.
President of ISVHLD 2015
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Hotel reservation is also possible via fax or regular mail. The selected hotels have limited capacities. It is recommended to book your hotel as early as possible.
- Abstracts must be submitted in English.
- All abstracts must contain original work that has not been published or presented identically on previous occasions.
- Indicate the preferred type of presentation (oral or poster).
- The title should be as brief as possible but long enough to indicate clearly the nature of the study. Abbreviations must not be used in the title.
- Abstract text is limited to 3,000 characters including spaces.
- Graphics and tables are accepted (max. 2 of each)
- Please check spelling and grammar carefully. All abstracts will be published as submitted.
- Use generic names. Commercial drug names may not be used.
Computer projection facilities (PowerPoint presentations) will be available in all meeting rooms. MCI will provide further information prior to the congress.
Selected posters will be discussed in the poster area of the Estrel Convention Center. Posters should be prepared in DIN A0 size (84 × 1189 mm), portrait format, in English language. MCI will provide further information prior to the congress.
Please note that the acceptance of your abstract does not include congress registration. At least one author (the first or the presenting author) is therefore kindly asked to register for the congress. The abstract will otherwise not be reviewed and will be waived from the program.
Please join us at the 15th International Symposium on Viral Hepatitis and Liver Disease to share your latest developments in the field of viral hepatitis and liver diseases.
We are very pleased to announce that the 15th ISVHLD will be organized in collaboration with 12th HepNet Symposium of the German Liver Foundation. Accordingly, we expect to welcome 1,500-2,000 participants and a great scope of sponsors and exhibitors.
Univ.-Prof. Dr. Michael P. Manns